Overview
- Media reports indicate the UK National Screening Committee is likely to advise against a national targeted programme, though no decision has been published.
- The committee is due to meet next month to make formal recommendations, following briefings that questioned cost-effectiveness.
- Rishi Sunak made a rare public intervention urging ministers not to shelve plans, arguing a targeted approach would save lives.
- Prostate Cancer UK warned it would be deeply disappointed by a rejection and highlighted its £42 million Transform trial, which it says could produce new evidence within about two years.
- The charity is pressing for updated NHS guidance so GPs can proactively offer PSA tests to higher-risk men, as prostate cancer remains the UK’s most common cancer with tens of thousands of new cases annually.